Cargando…
Extended Use of Histrelin Implant in Pediatric Patients
PURPOSE: Histrelin implant (HI) is a gonadotropin-releasing hormone agonist (GnRHa) used in pediatrics to treat central precocious puberty (CPP) and for pubertal suppression in transgender/non-binary (TG/NB) youth with gender dysphoria. HI is designed for annual removal/replacement; however, effecti...
Autores principales: | Pine-Twaddell, Elyse, Newfield, Ron S., Marinkovic, Maja |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Mary Ann Liebert, Inc., publishers
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10278025/ https://www.ncbi.nlm.nih.gov/pubmed/37342480 http://dx.doi.org/10.1089/trgh.2021.0130 |
Ejemplares similares
-
SAT-298 A Case of a Forgotten Histrelin Acetate Implant: Can Histrelin Acetate Implants Be Used for More Than a Year?
por: KV Krishnaraj, Balasundari, et al.
Publicado: (2019) -
Histrelin Implantation and Growth Outcomes in Children With Congenital Adrenal Hyperplasia: An Institutional Experience
por: Swendiman, Robert A, et al.
Publicado: (2019) -
Random unstimulated pediatric luteinizing hormone levels are not reliable in the assessment of pubertal suppression during histrelin implant therapy
por: Neely, E Kirk, et al.
Publicado: (2013) -
Gonadotropin Suppression for 7 Years After a Single Histrelin Implant for Precocious Puberty
por: Villalta, Douglas, et al.
Publicado: (2022) -
Experience with the once-yearly histrelin (GnRHa) subcutaneous implant in the treatment of central precocious puberty
por: Lewis, Katherine A, et al.
Publicado: (2009)